{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T19:32:52Z","timestamp":1784835172263,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81601852"],"award-info":[{"award-number":["81601852"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.cca.2019.08.027","type":"journal-article","created":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T15:09:11Z","timestamp":1566918551000},"page":"34-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Proteomic approaches in the discovery of potential urinary biomarkers of mucopolysaccharidosis type II"],"prefix":"10.1016","volume":"499","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0191-5854","authenticated-orcid":false,"given":"Xiaozhou","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yating","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wencan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyan","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6535-5967","authenticated-orcid":false,"given":"Chengbin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2019.08.027_bb0005","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.2147\/DDDT.S139601","article-title":"Development of idursulfase therapy for mucopolysaccharidosis type II (Hunter syndrome): the past, the present and the future","volume":"11","author":"Whiteman","year":"2017","journal-title":"Drug Des Devel Ther."},{"key":"10.1016\/j.cca.2019.08.027_bb0010","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.cca.2019.01.009","article-title":"Genetic analysis of 63 Chinese patients with mucopolysaccharidosis type II: functional characterization of seven novel IDS variants","volume":"491","author":"Zhang","year":"2019","journal-title":"Clin. Chim. Acta"},{"issue":"2","key":"10.1016\/j.cca.2019.08.027_bb0015","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ymgme.2014.12.299","article-title":"Cognitive, medical, and neuroimaging characteristics of attenuated mucopolysaccharidosis type II","volume":"114","author":"Yund","year":"2015","journal-title":"Mol. Genet. Metab."},{"issue":"4","key":"10.1016\/j.cca.2019.08.027_bb0020","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ymgme.2018.08.003","article-title":"Anatomical changes and pathophysiology of the brain in mucopolysaccharidosis disorders","volume":"125","author":"Bigger","year":"2018","journal-title":"Mol. Genet. Metab."},{"issue":"3","key":"10.1016\/j.cca.2019.08.027_bb0025","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ymgme.2018.07.001","article-title":"Critical review of current MPS guidelines and management","volume":"126","author":"Stapleton","year":"2019","journal-title":"Mol. Genet. Metab."},{"issue":"1\u20132","key":"10.1016\/j.cca.2019.08.027_bb0030","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ymgme.2016.10.001","article-title":"Proteomic analysis of mucopolysaccharidosis I mouse brain with two-dimensional polyacrylamide gel electrophoresis","volume":"120","author":"Ou","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.cca.2019.08.027_bb0035","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jprot.2014.03.035","article-title":"2DE: the phoenix of proteomics","volume":"104","author":"Oliveira","year":"2014","journal-title":"J. Proteome"},{"issue":"1-2","key":"10.1016\/j.cca.2019.08.027_bb0040","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ymgme.2018.07.013","article-title":"Evaluation of cerebrospinal fluid heparan sulfate as a biomarker of neuropathology in a murine model of mucopolysaccharidosis type II using high-sensitivity LC\/MS\/MS","volume":"125","author":"Tanaka","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.cca.2019.08.027_bb0045","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.cca.2018.11.001","article-title":"LC-MS\/MS method for simultaneous quantification of heparan sulfate and dermatan sulfate in urine by butanolysis derivatization","volume":"488","author":"Forni","year":"2019","journal-title":"Clin. Chim. Acta"},{"issue":"2","key":"10.1016\/j.cca.2019.08.027_bb0050","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1373\/clinchem.2014.225771","article-title":"Newborn screening for lysosomal storage diseases","volume":"61","author":"Gelb","year":"2015","journal-title":"Clin. Chem."},{"issue":"1\u20132","key":"10.1016\/j.cca.2019.08.027_bb0055","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ymgme.2013.04.002","article-title":"Review of clinical presentation and diagnosis of mucopolysaccharidosis IVA","volume":"110","author":"Hendriksz","year":"2013","journal-title":"Mol. Genet. Metab."},{"issue":"3","key":"10.1016\/j.cca.2019.08.027_bb0060","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ymgme.2006.01.005","article-title":"Heparin cofactor II-thrombin complex in MPS I: a biomarker of MPS disease","volume":"88","author":"Randall","year":"2006","journal-title":"Mol. Genet. Metab."},{"issue":"2","key":"10.1016\/j.cca.2019.08.027_bb0065","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10545-011-9369-6","article-title":"Longitudinal observations of serum heparin cofactor II-thrombin complex in treated Mucopolysaccharidosis I and II patients","volume":"35","author":"Clarke","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"issue":"2","key":"10.1016\/j.cca.2019.08.027_bb0070","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ymgme.2014.12.301","article-title":"Shotgun proteomics reveals possible mechanisms for cognitive impairment in Mucopolysaccharidosis I mice","volume":"114","author":"Baldo","year":"2015","journal-title":"Mol. Genet. Metab."},{"issue":"1","key":"10.1016\/j.cca.2019.08.027_bb0075","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ymgme.2016.03.003","article-title":"Integrated analysis of proteome and transcriptome changes in the mucopolysaccharidosis type VII mouse hippocampus","volume":"118","author":"Parente","year":"2016","journal-title":"Mol. Genet. Metab."},{"issue":"24","key":"10.1016\/j.cca.2019.08.027_bb0080","doi-asserted-by":"crossref","first-page":"12238","DOI":"10.1021\/acs.analchem.5b03232","article-title":"Proteomic discovery and development of a multiplexed targeted MRM-LC-MS\/MS assay for urine biomarkers of extracellular matrix disruption in Mucopolysaccharidoses I, II, and VI","volume":"87","author":"Heywood","year":"2015","journal-title":"Anal. Chem."},{"key":"10.1016\/j.cca.2019.08.027_bb0085","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4939-1872-0_1","article-title":"Biological sample collection for clinical proteomics: existing SOPs","volume":"1243","author":"Lygirou","year":"2015","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.cca.2019.08.027_bb0090","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/acel.12409","article-title":"Lysosomal storage and impaired autophagy lead to inflammasome activation in Gaucher macrophages","volume":"15","author":"Aflaki","year":"2016","journal-title":"Aging Cell"},{"issue":"11","key":"10.1016\/j.cca.2019.08.027_bb0095","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1002\/jnr.23822","article-title":"Treatment for Krabbe's disease: finding the combination","volume":"94","author":"Mikulka","year":"2016","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.cca.2019.08.027_bb0100","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/jnc.13138","article-title":"Immune dysfunction in Niemann-pick disease type C","volume":"136 Suppl 1","author":"Platt","year":"2016","journal-title":"J. Neurochem."},{"issue":"1","key":"10.1016\/j.cca.2019.08.027_bb0105","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/brain\/awx311","article-title":"Macrophage enzyme and reduced inflammation drive brain correction of mucopolysaccharidosis IIIB by stem cell gene therapy","volume":"141","author":"Holley","year":"2018","journal-title":"Brain."},{"issue":"2","key":"10.1016\/j.cca.2019.08.027_bb0110","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11011-012-9302-1","article-title":"Mucopolysaccharidosis type I: current knowledge on its pathophysiological mechanisms","volume":"27","author":"Campos","year":"2012","journal-title":"Metab. Brain Dis."},{"issue":"10","key":"10.1016\/j.cca.2019.08.027_bb0115","doi-asserted-by":"crossref","first-page":"5233","DOI":"10.4049\/jimmunol.168.10.5233","article-title":"Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by toll-like receptor 4","volume":"168","author":"Johnson","year":"2002","journal-title":"J Immunol (BaltimoreMd : 1950)"},{"issue":"5 Pt 1","key":"10.1016\/j.cca.2019.08.027_bb0120","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1203\/01.PDR.0000156510.96253.5A","article-title":"Joint and bone disease in mucopolysaccharidoses VI and VII: identification of new therapeutic targets and biomarkers using animal models","volume":"57","author":"Simonaro","year":"2005","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.cca.2019.08.027_bb0125","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.biochi.2016.05.004","article-title":"Neuronal sphingolipidoses: membrane lipids and sphingolipid activator proteins regulate lysosomal sphingolipid catabolism","volume":"130","author":"Sandhoff","year":"2016","journal-title":"Biochimie."},{"issue":"2","key":"10.1016\/j.cca.2019.08.027_bb0130","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.gene.2016.10.007","article-title":"Differential expression of microRNAs from miR-17 family in the cerebellum of mucopolysaccharidosis type I mice","volume":"595","author":"Pereira","year":"2016","journal-title":"Gene."},{"key":"10.1016\/j.cca.2019.08.027_bb0135","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12876-015-0338-7","article-title":"Activation of the prostaglandin D2 metabolic pathway in Crohn's disease: involvement of the enteric nervous system","volume":"15","author":"Le Loupp","year":"2015","journal-title":"BMC Gastroenterol."},{"issue":"12","key":"10.1016\/j.cca.2019.08.027_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114470","article-title":"Dexamethasone protects neonatal hypoxic-ischemic brain injury via L-PGDS-dependent PGD2-DP1-pERK signaling pathway","volume":"9","author":"Gonzalez-Rodriguez","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.cca.2019.08.027_bb0145","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1471-4159.2006.03753.x","article-title":"Lipocalin-type prostaglandin D synthase is up-regulated in oligodendrocytes in lysosomal storage diseases and binds gangliosides","volume":"97","author":"Mohri","year":"2006","journal-title":"J. Neurochem."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898119320224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898119320224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T16:33:05Z","timestamp":1721665985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898119320224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":29,"alternative-id":["S0009898119320224"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2019.08.027","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proteomic approaches in the discovery of potential urinary biomarkers of mucopolysaccharidosis type II","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2019.08.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}